MedPath

Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation

Not Applicable
Completed
Conditions
Paresthesia
Nerve Injury
Fracture
Mandibular Prognathism
Nerve Entrapments
Mandibular Nerve Injuries
Mandibular Hyperplasia
Mandibular Hypoplasia
Surgical Complication
Mandibular Retrognathism
Registration Number
NCT05205616
Lead Sponsor
University of California, San Francisco
Brief Summary

The aim of this prospective study is to analyze the postoperative paresthesias experienced in patients who undergo bilateral sagittal split osteotomies (BSSO) using an ultrasonic saw, versus a reciprocating saw. Patients included in the study are ages 15-45 scheduled to undergo BSSO surgery at the University of California, San Francisco. One side of the patient's mandible will be instrumented with either the Stryker Sonopet ultrasonic saw or traditional reciprocating saw, while the other side will receive the remaining intervention (determined via randomization on the day of surgery). Patient paresthesias will then be analyzed on each side for 3 months postoperatively (at postoperative days: 1, 7, 14, 28, and 84). Sensory examinations will be carried out by blinded examiners using von Frey hairs and two point discrimination testing. Patients will also subjectively rate their sensation on each side. The results will then be analyzed to determine if patient paresthesias, including the severity and duration, differed depending on which instrument was used, the ultrasonic or reciprocating saw.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Must be undergoing bilateral sagittal split osteotomy surgery with Dr. Saghezchi at UCSF
  • Must agree to return for all follow up visits.
  • Must not have any preexisting V3 nerve paresthesia
  • Must be below the age of 45.
Exclusion Criteria
  • Persons with preexisting V3 nerve paresthesias
  • Pre-pubertal children will be excluded (per routine practice for this type of surgery).
  • Patients with syndromic genetic conditions that demonstrate clearly different anatomy in the two sides of their jaws will be excluded since the two sides may not be "exchangeable".

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postoperative Hypoesthesia Experienced at 3monthsWithin 15 days of exact 3 months post-operation

Count of patient mandibles who exhibited \*\*any\*\* hypoesthesia at 3months post-operation (i.e. VFH does not equal 0.008g). VFH filaments measure the minimum weight which a dermatome in question can sense. In this study, the measurements were designed to have the following range: 0.008g, 0.02g, 0.04g, 0.07g, 0.16g, 0.4g, 0.6g, 1g, 1.4g, 2g, 4g, 6g, 8g, 10g, 15g, with 0.008g being no neurosensory deficit. Although 28 persons completed the study, only 21 patients presented for their 3 month followup time, which was defined as with-in 15 days of 90th day after operation. Therefore, the denominator for this outcome is 21, for each intervention arm. The numerator is the number of Left or Right chin areas that exhibited less than "normal" sensation.

Secondary Outcome Measures
NameTimeMethod
Unfavorable FractureThis outcome occurs during the surgery. It was measured on the same day.

When a saggital split osteotomy is performed, a controlled fracture of the mandibular ramus is induced which follows an exact intended path of fracture. An unfavorable fracture is one that does not follow this exact path of fracture, and needs to be surgically mended. An unfavorable fracture is associated with poorer post-operative recovery.

Trial Locations

Locations (2)

University of California, San Francisco Medical Center

🇺🇸

San Francisco, California, United States

UCSF Benioff Children's Hospital

🇺🇸

San Francisco, California, United States

University of California, San Francisco Medical Center
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.